Sana Biotechnology Stock: Time And Cash Burn Are The Enemies (NASDAQ:SANA)


Reflecting on the life sciences/medical sector it’s apparent that very different kinds of companies live under this umbrella. Big pharma involves huge companies with deep pipelines and outcomes that result in evolutionary change. At the other end of the spectrum are the

Be the first to comment

Leave a Reply

Your email address will not be published.